About ODDITY Tech Ltd. - Class A Ordinary Shares (ODD)
ODDITY Tech Ltd. is a dynamic company specializing in the development and marketing of innovative beauty and wellness products. Leveraging advanced technology and data analytics, the company creates personalized and experiential offerings that resonate with consumers. By integrating a blend of science and creativity, ODDITY Tech has positioned itself at the forefront of the beauty industry, striving to enhance the customer experience through unique product formulations and digital engagement strategies. Read More
NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (NASDAQ: ODD) today announced its financial results for the third quarter ended September 30, 2025.
ODDITY Tech Ltd. (NASDAQ: ODD) today announced the launch of METHODIQ, a medical telehealth platform delivering customized, high-efficacy treatments powered by online diagnosis – without needing to go to a doctor’s office or get lost in a drug store.
ODDITY Tech offers strong growth at a fair price. With high revenue growth, profitability, and a reasonable P/E ratio, it fits the 'affordable growth' investment strategy.
NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (“ODDITY”) (NASDAQ: ODD), today announced that it will release its third quarter 2025 financial results after the market close on Wednesday, November 19, 2025, to be followed by a conference call on Thursday, November 20, 2025, at 8:30 a.m. Eastern Time.
Tracking upward trends in value rankings can help investors uncover opportunities before they gain broader attention. Over the past week, Benzinga's system highlighted five technology stocks showing sharp improvements in value scores.
Discover ODDITY TECH LTD (ODD), a high-growth beauty tech stock with strong fundamentals and a bullish technical setup poised for a potential breakout.
ODDITY Tech (NASDAQ: ODD) beat Q2 2025 revenue and EPS estimates but saw a 13% stock drop post-earnings. Strong profitability contrasts with investor concerns over future growth. Full-year outlook raised, yet market reaction remains cautious.
